Literature DB >> 19223268

Endophenotypes in schizophrenia: a selective review.

Allyssa J Allen1, Mélina E Griss, Bradley S Folley, Keith A Hawkins, Godfrey D Pearlson.   

Abstract

BACKGROUND: Given the wealth of data in the literature on schizophrenia endophenotypes, it is useful to have one source to reference their frequency data. We reviewed the literature on disease-liability associated variants in structural and functional magnetic resonance images (MRI), sensory processing measures, neuromotor abilities, neuropsychological measures, and physical characteristics in schizophrenia patients (SCZ), their first-degree relatives (REL), and healthy controls (HC). The purpose of this review was to provide a summary of the existing data on the most extensively published endophenotypes for schizophrenia.
METHODS: We searched PubMed and MedLine for all studies on schizophrenia endophenotypes comparing SCZ to HC and/or REL to HC groups. Percent abnormal values, generally defined as >2 SD from the mean (in the direction of abnormality) and/or associated effect sizes (Cohen's d) were calculated for each study.
RESULTS: Combined, the articles reported an average 39.4% (SD=20.7%; range=2.2-100%) of abnormal values in SCZ, 28.1% (SD=16.6%; range=1.6-67.0%) abnormal values in REL, and 10.2% (SD=6.7%; range=0.0-34.6%) in HC groups.
CONCLUSIONS: These findings are reviewed in the context of emerging hypotheses on schizophrenia endophenotypes, as well as a discussion of clustering trends among the various intermediate phenotypes. In addition, programs for future research are discussed, as instantiated in a few recent large-scale studies on multiple endophenotypes across patients, relatives, and healthy controls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223268      PMCID: PMC2665704          DOI: 10.1016/j.schres.2009.01.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  249 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian family study of schizophrenia.

Authors:  Gregory W Price; Patricia T Michie; Julie Johnston; Hamish Innes-Brown; Aaron Kent; Peter Clissa; Assen V Jablensky
Journal:  Biol Psychiatry       Date:  2005-12-20       Impact factor: 13.382

3.  Inverse relationship of perinatal complications and eye tracking dysfunction in relatives of patients with schizophrenia: evidence for a two-factor model.

Authors:  D K Kinney; D L Levy; D A Yurgelun-Todd; S J Tramer; P S Holzman
Journal:  Am J Psychiatry       Date:  1998-07       Impact factor: 18.112

4.  P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis.

Authors:  B A Clementz; M A Geyer; D L Braff
Journal:  Biol Psychiatry       Date:  1997-05-15       Impact factor: 13.382

5.  Clinical and experimental characteristics of "hypothetically psychosis prone" college students.

Authors:  K Cadenhead; C Kumar; D Braff
Journal:  J Psychiatr Res       Date:  1996 Sep-Oct       Impact factor: 4.791

6.  Executive functioning deficits in hypothetically psychosis-prone college students.

Authors:  J A Suhr
Journal:  Schizophr Res       Date:  1997-10-17       Impact factor: 4.939

7.  Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset.

Authors:  L Marsh; D Harris; K O Lim; M Beal; A L Hoff; K Minn; J G Csernansky; S DeMent; W O Faustman; E V Sullivan; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  1997-12

8.  Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

Authors:  S M Lawrie; H Whalley; J N Kestelman; S S Abukmeil; M Byrne; A Hodges; J E Rimmington; J J Best; D G Owens; E C Johnstone
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

9.  The Wisconsin Card Sorting Test discriminates schizophrenic patients and their siblings.

Authors:  S Scarone; M Abbruzzese; O Gambini
Journal:  Schizophr Res       Date:  1993-08       Impact factor: 4.939

10.  Eye tracking, schizophrenic symptoms, and schizotypal personality disorder.

Authors:  R S Keefe; L J Siever; R C Mohs; A E Peterson; T R Mahon; R L Bergman; K L Davis
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989
View more
  54 in total

1.  Altered integrity of the right arcuate fasciculus as a trait marker of schizophrenia: a sibling study using tractography-based analysis of the whole brain.

Authors:  Chen-Hao Wu; Tzung-Jeng Hwang; Yu-Jen Chen; Yun-Chin Hsu; Yu-Chun Lo; Chih-Min Liu; Hai-Gwo Hwu; Chen-Chung Liu; Ming H Hsieh; Yi Ling Chien; Chung-Ming Chen; Wen-Yih Isaac Tseng
Journal:  Hum Brain Mapp       Date:  2014-11-04       Impact factor: 5.038

2.  Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives.

Authors:  Shashwath A Meda; Adrienne Gill; Michael C Stevens; Raymond P Lorenzoni; David C Glahn; Vince D Calhoun; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan; Gunvant Thaker; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2012-03-07       Impact factor: 13.382

3.  Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.

Authors:  Wei Lei; Wei Deng; Mingli Li; Zongling He; Yuanyuan Han; Chaohua Huang; Xiaohong Ma; Qiang Wang; Wanjun Guo; Yinfei Li; Lijun Jiang; Qiyong Gong; Xun Hu; Nanyin Zhang; Tao Li
Journal:  Psychiatry Res       Date:  2015-09-11       Impact factor: 3.222

Review 4.  Brain Theranostics and Radiotheranostics: Exosomes and Graphenes In Vivo as Novel Brain Theranostics.

Authors:  Minseok Suh; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2018-11-09

5.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

Review 6.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 7.  Genetics of Childhood-onset Schizophrenia 2019 Update.

Authors:  Jennifer K Forsyth; Robert F Asarnow
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-10-17

8.  Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia.

Authors:  Shashwath A Meda; Gualberto Ruaño; Andreas Windemuth; Kasey O'Neil; Clifton Berwise; Sabra M Dunn; Leah E Boccaccio; Balaji Narayanan; Mohan Kocherla; Emma Sprooten; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney; Brett A Clementz; Vince D Calhoun; Godfrey D Pearlson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

Review 9.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

10.  Convergent approaches for defining functional imaging endophenotypes in schizophrenia.

Authors:  Godfrey D Pearlson; Vince D Calhoun
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.